Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES FULFORD INDIA ALKEM LABORATORIES/
FULFORD INDIA
 
P/E (TTM) x 24.5 398.8 6.1% View Chart
P/BV x 5.9 6.2 95.1% View Chart
Dividend Yield % 0.8 0.1 969.3%  

Financials

 ALKEM LABORATORIES   FULFORD INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
FULFORD INDIA
Mar-14
ALKEM LABORATORIES/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs2,720942 288.7%   
Low Rs1,660450 369.0%   
Sales per share (Unadj.) Rs697.9691.4 100.9%  
Earnings per share (Unadj.) Rs96.111.5 838.6%  
Cash flow per share (Unadj.) Rs117.315.4 763.5%  
Dividends per share (Unadj.) Rs25.002.00 1,250.0%  
Dividend yield (eoy) %1.10.3 397.2%  
Book value per share (Unadj.) Rs515.2380.0 135.6%  
Shares outstanding (eoy) m119.573.90 3,065.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.11.0 311.8%   
Avg P/E ratio x22.860.7 37.5%  
P/CF ratio (eoy) x18.745.3 41.2%  
Price / Book Value ratio x4.31.8 232.1%  
Dividend payout %26.017.4 149.1%   
Avg Mkt Cap Rs m261,8792,714 9,647.8%   
No. of employees `00014.30.4 3,227.7%   
Total wages/salary Rs m15,055505 2,981.2%   
Avg. sales/employee Rs Th5,822.66,073.0 95.9%   
Avg. wages/employee Rs Th1,050.51,137.4 92.4%   
Avg. net profit/employee Rs Th802.0100.7 796.6%   
INCOME DATA
Net Sales Rs m83,4442,696 3,094.6%  
Other income Rs m1,042125 831.1%   
Total revenues Rs m84,4862,822 2,994.0%   
Gross profit Rs m14,734-46 -31,754.1%  
Depreciation Rs m2,52815 16,628.9%   
Interest Rs m65110 6,848.4%   
Profit before tax Rs m12,59854 23,200.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,10510 11,508.3%   
Profit after tax Rs m11,49345 25,711.6%  
Gross profit margin %17.7-1.7 -1,026.1%  
Effective tax rate %8.817.7 49.6%   
Net profit margin %13.81.7 830.8%  
BALANCE SHEET DATA
Current assets Rs m54,9601,738 3,161.7%   
Current liabilities Rs m32,433545 5,954.3%   
Net working cap to sales %27.044.3 61.0%  
Current ratio x1.73.2 53.1%  
Inventory Days Days8048 164.2%  
Debtors Days Days724 1,676.0%  
Net fixed assets Rs m32,71012 274,872.3%   
Share capital Rs m23939 613.1%   
"Free" reserves Rs m61,3681,443 4,252.8%   
Net worth Rs m61,6071,482 4,157.0%   
Long term debt Rs m1,5920-   
Total assets Rs m99,4332,077 4,788.0%  
Interest coverage x20.46.7 303.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.3 64.6%   
Return on assets %12.22.6 467.9%  
Return on equity %18.73.0 618.5%  
Return on capital %21.04.3 486.9%  
Exports to sales %19.10-   
Imports to sales %3.024.5 12.2%   
Exports (fob) Rs m15,917NA-   
Imports (cif) Rs m2,483659 376.6%   
Fx inflow Rs m16,06117 93,379.1%   
Fx outflow Rs m2,483673 368.8%   
Net fx Rs m13,578-656 -2,070.0%   
CASH FLOW
From Operations Rs m5,85190 6,500.9%  
From Investments Rs m-7,414105 -7,087.5%  
From Financial Activity Rs m792-14 -5,613.5%  
Net Cashflow Rs m-731181 -405.0%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 33.1 3.8 871.1%  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 21.2 -  
Shareholders   68,381 4,783 1,429.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  STRIDES PHARMA SCIENCE  FDC  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 470 Points Lower; Tata Motors & Tata Steel Fall 6%(Closing)

Indian share markets witnessed huge selling pressure today, in line with global equities and fell on to bearish territory.

Related Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 18, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - CIPLA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS